Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

Hui Wen Lo, Sheng Chieh Hsu, Mohamed Ali-Seyed, Mehmet Gunduz, Weiya Xia, Yongkun Wei, Geoffrey Bartholomeusz, Jin Yuan Shih, Mien Chie Hung*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

446 Scopus citations

Abstract

Epidermal growth factor receptor (EGFR) exists in the nucleus of highly proliferative cells where it functions as a transcription factor. Although EGFR has transactivational activity, it lacks a DNA binding domain and, therefore, may require a DNA binding transcription cofactor for its transcriptional function. Here, we report that EGFR physically interacts with signal transducers and activators of transcription 3 (STAT3) in the nucleus, leading to transcriptional activation of inducible nitric oxide synthase (iNOS). In breast carcinomas, nuclear EGFR positively correlates with iNOS. This study describes a mode of transcriptional control involving cooperated efforts of STAT3 and nuclear EGFR. Our work suggests that the deregulated iNOS/NO pathway may partly contribute to the malignant biology of tumor cells with high levels of nuclear EGFR and STAT3.

Original languageEnglish
Pages (from-to)575-589
Number of pages15
JournalCancer Cell
Volume7
Issue number6
DOIs
StatePublished - 06 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway'. Together they form a unique fingerprint.

Cite this